To determine whether the LUCAT1-ALYREF interplay mediates TTYH3-mediated NSCLC progression, we used LUCAT1-knockdown, ALYREF-overexpressing, ALYREF-knockdown, and TTYH3-overexpressing NSCLC cells. The gene discussed is ALYREF; the disease is non-small cell lung carcinoma.